Recent Lessons

Show all results for ""

Feature Overview

Ace your exams with our all-in-one platform for creating and sharing quizzes and tests.

Quizzes

Create quizzes and tests automatically from your content using AI.

Flashcards

Automatically turn your notes into digital flashcards.

Share, Export & Embed

Share with classmates or export to Excel and your learning management system.

Stats & Reporting

Auto-grading quizzes and tests with detailed stats and reports.

Mobile Apps

The smarter way to study – wherever you are.

Pricing Schools Business

Features Pricing Schools Business

Managing Critically Ill Patients with MDR S.maltophilia Infections

8 Questions

0 Views

Managing Critically Ill Patients with MDR S.maltophilia Infections

Choose a study mode

Play Quiz

Study Flashcards

Spaced Repetition

Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary goal of the review regarding pan-drug resistant MDR S. maltophilia in critically ill patients with HAP/VAP?

To present strategies for effective antibiotic treatment (correct)

To discuss the risk factors associated with mortality rates

To investigate the genetic mechanisms of antibiotic resistance

To evaluate the efficacy of broad-spectrum agents

What type of bacteria is Stenotrophomonas (S.) spp?

Non-fermentative Gram-negative bacteria (correct)

Fermentative Gram-positive bacteria

Non-fermentative Gram-positive bacteria

Fermentative Gram-negative bacteria

Why has the clinical management of MDR GNB infections become more complex?

Due to the high levels of resistance expressed by the bacteria (correct)

Due to the decreased efficacy of broad-spectrum agents

Due to the increased occurrence of colonized patients

Due to the development of new antibiotic agents

What is a common characteristic of MDR GNB, including S. maltophilia?

Expression of high levels of resistance (A) Signup and view all the answers

What was the cutoff date for the search of published studies in the review?

April 2019 (C) Signup and view all the answers

What is a common risk factor associated with HAP/VAP due to S. maltophilia?

Specific risk conditions (B) Signup and view all the answers

What is the significance of Stenotrophomonas (S.) spp. in the context of nosocomial and community-acquired infections?

It is a noticeable microbe of nosocomial and community-acquired infections (D) Signup and view all the answers

What is the consequence of the increasing resistance of S. maltophilia isolates?

Healthcare facilities experience an ingathering of colonized patients (A) Signup and view all the answers

Study Notes

Objectives of the Review

Discuss current data and outcomes for managing and treating critically ill patients with Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) caused by pan-drug resistant Multidrug-Resistant (MDR) Stenotrophomonas maltophilia.
Present strategies for effective antibiotic treatment against MDR S. maltophilia isolates.
Review mortality rates and common influencing risk factors for patients with pan-resistance.

Background and Context

Multidrug-Resistant Gram-Negative Bacteria (MDR GNB) infections have limited therapeutic options.
Pan-resistant phenotypes make clinical management more complex and challenging.
Stenotrophomonas (S.) maltophilia is a non-fermentative Gram-Negative Bacteria (GNB) causing nosocomial and community-acquired infections.
Despite broad-spectrum agents, S. maltophilia isolates have increased resistance, leading to colonization and infections in patients with specific risk conditions.

Methodology

Performed a major search of online databases until April 2019.
Reviewed experimental and observational studies, online journals, and expert opinions on VAP/HAP due to S. maltophilia.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Description

This quiz reviews current data and outcomes for managing critically ill patients with HAP/VAP due to pan-drug resistant MDR S.maltophilia, including effective antibiotic treatment strategies and mortality rates.